NEWS & PRESS RELEASE
Our technology has been presented at 2021 TVT to be held on July 20-22 in Miami, FL. Specifically, Dr. Torsten Vahl, MD, spoke about "Circumferential Mitral Leaflet Capture and Annular Resizing – InnovHeart".
Our Saturn Device was presented at 2021 EuroPCR held on May 18-20. Dr. Paolo Denti, MD, presented the earliest clinical results of the TransApical implant, while Dr. Torsten Vahl, MD, illustrated the advancements in the TransSeptal technology. Full videos available...
Industry Leader to Guide Company and the Saturn TMVR Programin its Next Phase of Growth InnovHeart s.r.l. announced today the appointment of David James Wilson, an experienced healthcare and medical device executive as Chief Executive Officer of the company and...
InnovHeart raises $55 million in Series C financing to further develop the Trans-septal Saturn Transcatheter Mitral Valve Replacement System
InnovHeart and Grand Pharmaceutical Group Enter Into an Exclusive License Agreement to Develop and Commercialize the Saturn TMVR Device in Greater China Milan, January 27, 2022 - InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement...
“Learning and innovation go hand in hand.
The arrogance of success is to think that what you did yesterday
will be sufficient for tomorrow.”